Advertisement
Screener

Skye Bioscience, Inc. (SKYE) Foreign Currency Transaction Gain Loss Realized After Tax

1.5 / 5 stars · 13/42 Roast Me

Skye Bioscience, Inc. Foreign Currency Transaction Gain Loss Realized After Tax

Skye Bioscience, Inc. (SKYE) reported Foreign Currency Transaction Gain Loss Realized After Tax of -$1.09 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Income Statement › Other Income

us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax · last filed 2026-03-10

  • Skye Bioscience, Inc. foreign currency transaction gain loss realized after tax for fiscal 2025 was -$1.09M, a 2270.89% decline from fiscal 2024.
  • Skye Bioscience, Inc. foreign currency transaction gain loss realized after tax for fiscal 2024 was $49.98K, a 446.69% increase from fiscal 2023.
  • Skye Bioscience, Inc. foreign currency transaction gain loss realized after tax for fiscal 2023 was $9.14K.
  • Skye Bioscience, Inc. foreign currency transaction gain loss realized after tax for fiscal 2022 was -$3.35K.
Period endForeign Currency Transaction Gain Loss Realized After Tax 12 monthForeign Currency Transaction Gain Loss Realized After Tax 12 month as first filed
2025-12-31-$1.09M
10-K · filed 2026-03-10
2024-12-31$49.98K
10-K · filed 2026-03-10
-$49.99K
10-K · filed 2025-03-20
2023-12-31$9.14K
10-K · filed 2025-03-20
-$9.14K
10-K · filed 2024-03-22
2022-12-31-$3.35K
10-K · filed 2024-03-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
HYPERION DEFI, INC. (HYPD)United States$0.065B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99